222 related articles for article (PubMed ID: 18958510)
1. Characterization of the bone phenotype in ClC-7-deficient mice.
Neutzsky-Wulff AV; Karsdal MA; Henriksen K
Calcif Tissue Int; 2008 Dec; 83(6):425-37. PubMed ID: 18958510
[TBL] [Abstract][Full Text] [Related]
2. Severe developmental bone phenotype in ClC-7 deficient mice.
Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acid flux in osteoclasts from patients harboring a G215R mutation in ClC-7.
Henriksen K; Gram J; Neutzsky-Wulff AV; Jensen VK; Dziegiel MH; Bollerslev J; Karsdal MA
Biochem Biophys Res Commun; 2009 Jan; 378(4):804-9. PubMed ID: 19070589
[TBL] [Abstract][Full Text] [Related]
4. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
5. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
[TBL] [Abstract][Full Text] [Related]
6. The role of chloride channels in osteoclasts: ClC-7 as a target for osteoporosis treatment.
Schaller S; Henriksen K; Sørensen MG; Karsdal MA
Drug News Perspect; 2005 Oct; 18(8):489-95. PubMed ID: 16391718
[TBL] [Abstract][Full Text] [Related]
7. Ion transporters involved in acidification of the resorption lacuna in osteoclasts.
Henriksen K; Sørensen MG; Jensen VK; Dziegiel MH; Nosjean O; Karsdal MA
Calcif Tissue Int; 2008 Sep; 83(3):230-42. PubMed ID: 18787885
[TBL] [Abstract][Full Text] [Related]
8. Dissolution of the inorganic phase of bone leading to release of calcium regulates osteoclast survival.
Nielsen RH; Karsdal MA; Sørensen MG; Dziegiel MH; Henriksen K
Biochem Biophys Res Commun; 2007 Sep; 360(4):834-9. PubMed ID: 17631274
[TBL] [Abstract][Full Text] [Related]
9. Are nonresorbing osteoclasts sources of bone anabolic activity?
Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
[TBL] [Abstract][Full Text] [Related]
10. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.
Lange PF; Wartosch L; Jentsch TJ; Fuhrmann JC
Nature; 2006 Mar; 440(7081):220-3. PubMed ID: 16525474
[TBL] [Abstract][Full Text] [Related]
11. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
[TBL] [Abstract][Full Text] [Related]
12. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation.
Schaller S; Henriksen K; Sveigaard C; Heegaard AM; Hélix N; Stahlhut M; Ovejero MC; Johansen JV; Solberg H; Andersen TL; Hougaard D; Berryman M; Shiødt CB; Sørensen BH; Lichtenberg J; Christophersen P; Foged NT; Delaissé JM; Engsig MT; Karsdal MA
J Bone Miner Res; 2004 Jul; 19(7):1144-53. PubMed ID: 15176998
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
14. Osteoclast polarization is not required for degradation of bone matrix in rachitic FGF23 transgenic mice.
Hollberg K; Marsell R; Norgård M; Larsson T; Jonsson KB; Andersson G
Bone; 2008 Jun; 42(6):1111-21. PubMed ID: 18346951
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.
Weinert S; Jabs S; Supanchart C; Schweizer M; Gimber N; Richter M; Rademann J; Stauber T; Kornak U; Jentsch TJ
Science; 2010 Jun; 328(5984):1401-3. PubMed ID: 20430974
[TBL] [Abstract][Full Text] [Related]
16. Characterization of osteoclasts from patients harboring a G215R mutation in ClC-7 causing autosomal dominant osteopetrosis type II.
Henriksen K; Gram J; Schaller S; Dahl BH; Dziegiel MH; Bollerslev J; Karsdal MA
Am J Pathol; 2004 May; 164(5):1537-45. PubMed ID: 15111300
[TBL] [Abstract][Full Text] [Related]
17. A specific subtype of osteoclasts secretes factors inducing nodule formation by osteoblasts.
Henriksen K; Andreassen KV; Thudium CS; Gudmann KN; Moscatelli I; Crüger-Hansen CE; Schulz AS; Dziegiel MH; Richter J; Karsdal MA; Neutzsky-Wulff AV
Bone; 2012 Sep; 51(3):353-61. PubMed ID: 22722081
[TBL] [Abstract][Full Text] [Related]
18. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
[TBL] [Abstract][Full Text] [Related]
19. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.
Kasper D; Planells-Cases R; Fuhrmann JC; Scheel O; Zeitz O; Ruether K; Schmitt A; Poët M; Steinfeld R; Schweizer M; Kornak U; Jentsch TJ
EMBO J; 2005 Mar; 24(5):1079-91. PubMed ID: 15706348
[TBL] [Abstract][Full Text] [Related]
20. Reduced osteoblastic population and defective mineralization in osteopetrotic (op/op) mice.
Sakagami N; Amizuka N; Li M; Takeuchi K; Hoshino M; Nakamura M; Nozawa-Inoue K; Udagawa N; Maeda T
Micron; 2005; 36(7-8):688-95. PubMed ID: 16182547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]